Literature DB >> 17395754

Toward further mapping of the association between the IL2RA locus and type 1 diabetes.

Hui-Qi Qu1, Alexander Montpetit, Bing Ge, Thomas J Hudson, Constantin Polychronakos.   

Abstract

A novel type 1 diabetes locus was mapped to the interleukin-2 receptor alpha gene (IL2RA) on chromosome 10p15.1, encoding an important modulator of immunity. The aim of the current study was to confirm the association of IL2RA with type 1 diabetes and to attempt further mapping of the genetic effect with a new set of 12 single nucleotide polymorphisms (SNPs). We genotyped 949 nuclear family trios with one type 1 diabetes-affected offspring and two parents (2,847 individuals). Two of the 12 IL2RA SNPs genotyped (rs706778 and rs3118470) had statistically significant type 1 diabetes association (P = 6.96 x 10(-4) and 8.63 x 10(-4), respectively). Both SNPs are located in the 5' end of the long intron 1 within 3 kb of each other and are in high linkage disequilibrium (D' = 0.997, r(2) = 0.613). The A-C haplotype (frequency = 0.331) was associated with increased type 1 diabetes risk (P = 3.02 x 10(-4)). Our study identifies two markers in the IL2RA gene that are significantly associated with type 1 diabetes, supporting IL2RA as a promising candidate gene for type 1 diabetes and suggesting a potential role of IL2Ralpha in the pathogenesis of type 1 diabetes, likely involving regulatory T-cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395754     DOI: 10.2337/db06-1555

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  37 in total

1.  Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis.

Authors:  Marie-Claude Babron; Hervé Perdry; Adam E Handel; Sreeram V Ramagopalan; Vincent Damotte; Bertrand Fontaine; Bertram Müller-Myhsok; George C Ebers; Françoise Clerget-Darpoux
Journal:  Eur J Hum Genet       Date:  2011-11-16       Impact factor: 4.246

Review 2.  Understanding type 1 diabetes through genetics: advances and prospects.

Authors:  Constantin Polychronakos; Quan Li
Journal:  Nat Rev Genet       Date:  2011-10-18       Impact factor: 53.242

3.  Haplotypic analysis of Wellcome Trust Case Control Consortium data.

Authors:  Brian L Browning; Sharon R Browning
Journal:  Hum Genet       Date:  2008-01-26       Impact factor: 4.132

Review 4.  Genome-wide association studies in type 1 diabetes.

Authors:  Struan F A Grant; Hakon Hakonarson
Journal:  Curr Diab Rep       Date:  2009-04       Impact factor: 4.810

5.  The type I diabetes association of the IL2RA locus.

Authors:  H-Q Qu; J P Bradfield; A Bélisle; S F A Grant; H Hakonarson; C Polychronakos
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

6.  The Type I Diabetes Genetics Consortium 'Rapid Response' family-based candidate gene study: strategy, genes selection, and main outcome.

Authors:  C Julier; B Akolkar; P Concannon; G Morahan; C Nierras; A Pugliese
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

7.  IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D).

Authors:  Antonio Alcina; María Fedetz; Dorothy Ndagire; Oscar Fernández; Laura Leyva; Miguel Guerrero; María M Abad-Grau; Carmen Arnal; Concepción Delgado; Miguel Lucas; Guillermo Izquierdo; Fuencisla Matesanz
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

8.  IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production.

Authors:  Lisa M Maier; Christopher E Lowe; Jason Cooper; Kate Downes; David E Anderson; Christopher Severson; Pamela M Clark; Brian Healy; Neil Walker; Cristin Aubin; Jorge R Oksenberg; Stephen L Hauser; Alistair Compston; Stephen Sawcer; Philip L De Jager; Linda S Wicker; John A Todd; David A Hafler
Journal:  PLoS Genet       Date:  2009-01-02       Impact factor: 5.917

9.  Genetic heterogeneity in latent autoimmune diabetes is linked to various degrees of autoimmune activity: results from the Nord-Trøndelag Health Study.

Authors:  Elin Pettersen; Frank Skorpen; Kirsti Kvaløy; Kristian Midthjell; Valdemar Grill
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

10.  Idd9.1 locus controls the suppressive activity of FoxP3+CD4+CD25+ regulatory T-cells.

Authors:  Jun Yamanouchi; Maria-Carmen Puertas; Joan Verdaguer; Paul A Lyons; Daniel B Rainbow; Giselle Chamberlain; Kara M Hunter; Laurence B Peterson; Linda S Wicker; Pere Santamaria
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.